Bank of Montreal’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-165,632
Closed -$1.13M 3693
2024
Q3
$1.13M Buy
+165,632
New +$1.3M ﹤0.01% 1976
2022
Q1
Sell
-187,216
Closed -$6.21M 4199
2021
Q4
$6.21M Buy
187,216
+97,221
+108% +$3.91M ﹤0.01% 1146
2021
Q3
$3.68M Sell
89,995
-3,708
-4% -$135K ﹤0.01% 1783
2021
Q2
$3.49M Buy
93,703
+36,553
+64% +$1.35M ﹤0.01% 1783
2021
Q1
$2.25M Buy
57,150
+3,500
+7% +$157K ﹤0.01% 1731
2020
Q4
$2.27M Sell
53,650
-7,513
-12% -$345K ﹤0.01% 1761
2020
Q3
$3.5M Buy
+61,163
New +$3.24M ﹤0.01% 1409

Other funds holding GDRX

Bank of Montreal's GDRX Position: Q4 2024 in Review

Bank of Montreal sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 165,632 shares — an estimated $1.13M sold.

Bank of Montreal first reported a position in GDRX in Q3 2020 and held it in 7 quarters. The position peaked at $6.21M in Q4 2021. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

  • Bank of Montreal reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 165,632 GoodRx Holdings shares in Q4 2024, an estimated $1.13M.
  • Bank of Montreal first reported a position in GoodRx Holdings in Q3 2020 and held it in 7 quarters.
  • Bank of Montreal's GoodRx Holdings position peaked at $6.21M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.